ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

The researchers reviewed data on symptom severity and COVID-19 vaccination status. Significantly more cancer survivors had ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW ...

A new study examines cancer prevalence across hundreds of vertebrate species. Every multicellular creature, whether soaring ...

This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...

Hurricanes are not the only weather events that can put cancer care delivery at risk; wildfires can also cause population ...

Certain foods and habits can impact your chances of getting cancer in your lifetime. Here, we share the latest research as ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on oral conditions represents a landmark moment ...

Scientists are using artificial intelligence to better capture how healthy cells surrounding tumors influence cancer cell behavior and how those interactions can inform treatments.

Patients expressed concern that overreliance on artificial intelligence (AI) could lead to clinicians losing their skills, ...

Picking out produce at the grocery store used to be a basic task you could do without overthinking too much. Now, choosing ...